Vecuronium Bromide for Injection, a non-depolarizing neuromuscular blocker, is indicated as an adjunct to general anesthesia. Teva announced the reintroduction and availability of Vecuronium Bromide ...
Vecuronium Bromide, a neuromuscular blocker, is indicated as adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ...
SCHAUMBURG, Ill., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of vecuronium bromide for injection, a neuromuscular blocking agent, in 10 and ...
Sagent Pharmaceuticals Inc has expanded a nationwide recall of vecuronium bromide for injection 10 mg, the US Food and Drug Administration (FDA) said today. Vecuronium bromide for injection is a ...
January 13, 2012 — The US Food and Drug Administration (FDA) yesterday issued an updated guidance on voluntary product recalls involving Bedford Laboratories injection drugs that were initially made ...
BEDFORD, Ohio, Jan. 10, 2012 /PRNewswire/ -- Bedford Laboratories™ today issued updated guidance on the following nationwide voluntary product recalls originally issued on August 2, 2011: Lot 1942980 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results